Literature DB >> 25694201

Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.

Karen G Chartier1, Katherine Sanchez, Therese K Killeen, Allison Burrow, Thomas Carmody, Tracy L Greer, Madhukar H Trivedi.   

Abstract

BACKGROUND AND OBJECTIVES: Gender-specific factors associated with stimulant abstinence severity were examined in a stimulant abusing or dependent residential treatment sample (N = 302).
METHOD: Bivariate statistics tested gender differences in stimulant abstinence symptoms, measured by participant-reported experiences of early withdrawal. Multivariate linear regression examined gender and other predictors of stimulant abstinence symptom severity.
RESULTS: Women compared to men reported greater stimulant abstinence symptom severity. Anxiety disorders and individual anxiety-related abstinence symptoms accounted for this difference. African American race/ethnicity was predictive of lower stimulant abstinence severity. DISCUSSION AND
CONCLUSIONS: Women were more sensitive to anxiety-related stimulant withdrawal symptoms. SCIENTIFIC SIGNIFICANCE: Clinics that address anxiety-related abstinence symptoms, which more commonly occur in women, may improve treatment outcome. © American Academy of Addiction Psychiatry.

Entities:  

Keywords:  anxiety; early withdrawal symptoms; gender; stimulant abstinence severity

Mesh：

Substances：

Year:  2015        PMID： 25694201      PMCID： PMC4803500          DOI： 10.1111/ajad.12190

Source DB:  PubMed          Journal:  Am J Addict        ISSN： 1055-0496


  14 in total

Review 1.  Substance abuse treatment entry, retention, and outcome in women: a review of the literature.

Authors:  Shelly F Greenfield; Audrey J Brooks; Susan M Gordon; Carla A Green; Frankie Kropp; R Kathryn McHugh; Melissa Lincoln; Denise Hien; Gloria M Miele
Journal:  Drug Alcohol Depend       Date:  2006-06-08       Impact factor: 4.492

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Risk factors in the relationship between gender and crack/cocaine.

Authors:  C W Lejuez; Marina A Bornovalova; Elizabeth K Reynolds; Stacey B Daughters; John J Curtin
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

4.  Comorbidities and race/ethnicity among adults with stimulant use disorders in residential treatment.

Authors:  Katherine Sanchez; Karen G Chartier; Tracy L Greer; Robrina Walker; Thomas Carmody; Chad D Rethorst; Kolette M Ring; Adriane M Dela Cruz; Madhukar H Trivedi
Journal:  J Ethn Subst Abuse       Date:  2015-01-12       Impact factor: 1.507

5.  Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.

Authors:  K M Kampman; A I Alterman; J R Volpicelli; I Maany; E S Muller; D D Luce; E M Mulholland; A F Jawad; G A Parikh; F D Mulvaney; R M Weinrieb; C P O'Brien
Journal:  Psychol Addict Behav       Date:  2001-03

Review 6.  Understanding and treating comorbid anxiety disorders in substance users: review and future directions.

Authors:  Kate Wolitzky-Taylor; Joachim T Operskalski; Richard Ries; Michelle G Craske; Peter Roy-Byrne
Journal:  J Addict Med       Date:  2011-12       Impact factor: 3.702

7.  Women with methamphetamine dependence: research on etiology and treatment.

Authors:  Judith B Cohen; Rivka Greenberg; Joshua Uri; Mary Halpin; Joan E Zweben
Journal:  J Psychoactive Drugs       Date:  2007-11

8.  Gender differences in cocaine dependence.

Authors:  Lisa M Najavits; Kristin M Lester
Journal:  Drug Alcohol Depend       Date:  2008-06-20       Impact factor: 4.492

Review 9.  Gender differences in methamphetamine use and responses: a review.

Authors:  Dean E Dluzen; Bin Liu
Journal:  Gend Med       Date:  2008-03

10.  Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.

Authors:  Madhukar H Trivedi; Tracy L Greer; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Diane Warden; Kolette M Ring; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes
Journal:  Trials       Date:  2011-09-19       Impact factor: 2.279
View more
  3 in total

1.  A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.

Authors:  LaTrice Montgomery; Ann Kathleen Burlew; Angela M Haeny; Chizara A Jones
Journal:  Psychol Addict Behav       Date:  2019-06-27

2.  When Stimulant Use Becomes Problematic: Examining the Role of Coping Styles.

Authors:  Hannah A Carlon; Gabriel Peters; Margo C Villarosa-Hurlocker
Journal:  Subst Use Misuse       Date:  2021-12-29       Impact factor: 2.362

3.  Cross-Sectional Associations Among Symptoms of Pain, Irritability, and Depression and How These Symptoms Relate to Social Functioning and Quality of Life: Findings From the EMBARC and STRIDE Studies and the VitalSign6 Project.

Authors:  Manish K Jha; Alan Schatzberg; Abu Minhajuddin; Cherise Chin Fatt; Taryn L Mayes; Madhukar H Trivedi
Journal:  J Clin Psychiatry       Date:  2021-04-13       Impact factor: 5.906
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.